Skip to main content
Clinical Trials/JPRN-jRCTb040190118
JPRN-jRCTb040190118
Completed
未知

Therapeutic angiogenesis by cell transplantation with adipose-derived regenerative cells for critical limb ischemia - TACT-ADRC

Murohara Toyoaki0 sites29 target enrollmentFebruary 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
critical limb ischemia
Sponsor
Murohara Toyoaki
Enrollment
29
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The results of this multicenter clinical trial demonstrate the safety, feasibility, and efficacy of transplanting autologous adipose tissue-derived mesenchymal stem cell progenitor cells for the purpose of antiangiogenic therapy.

Registry
who.int
Start Date
February 20, 2020
End Date
November 23, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Murohara Toyoaki

Eligibility Criteria

Inclusion Criteria

  • Target disease: PAD, TAO, and Collagen disease\-associated vasculitis
  • Patients with
  • (1\) 25\<\= Age \<80
  • (2\) CLI (Fontaine III\-IV), who are not candidates for conventional therapies any more, including surgical revascularization
  • (3\) informed consent

Exclusion Criteria

  • Patients with
  • (1\) Insufficient amount of adipose tissue
  • (2\) No informed consent
  • (3\) Expectation of life \< 1 year
  • (4\) A past 5 years or current history of malignant disease
  • (5\) Untreated coronary heart disease or cerebrovascular diseases
  • (6\) Untreated diabetic retinopathy
  • (7\) Laboratory signs of chronic or acute inflammation
  • (8\) Severe liver or kidney dysfunction
  • (9\) Severe anemia or pancytopenia

Outcomes

Primary Outcomes

Not specified

Similar Trials